InspireMD shareholders approve authorized share increase to 250M at annual meeting

Proposal No. 2 – Increase in Authorized Shares. The stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company’s common stock from 150,000,000 shares to 250,000,000 shares. The votes were as follows: For Against Withheld Broker Non-Votes 31,577,297 3,009,107 44,944 0

Proposal No. 3 - Ratification of Auditors. The stockholders ratified the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the 2026 fiscal year. The votes were as follows: For Against Abstain 34,355,150 244,248 31,950

Proposal No. 1 - Election of Directors. The stockholders re-elected Marvin Slosman, Raymond Cohen and Dan Dearen to serve on the board of directors of the Company, as Class 3 directors, for a term of three years or until their respective successor is elected and qualified. The votes were as follows: Director Name For Withheld Broker Non-Votes Marvin Slosman 25,086,284 1,728,950 7,816,114 Raymond Cohen 22,733,263 4,081,971 7,816,114 Dan Dearen 22,750,906 4,064,328 7,816,114